GO:0032946 positive regulation of mononuclear cell proliferation: Immune Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032946 describes any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation, a central event in adaptive and innate immunity.
• Mononuclear cells include T cells, B cells, monocytes and natural killer cells; their controlled expansion is required for effective host defense and is dysregulated in autoimmunity and cancer.
• Key positive regulators include cytokines such as IL-2 and IL-15, costimulatory receptors like CD28, and transcription factors such as NF-kB and STAT5.
• Dysregulated positive regulation of mononuclear cell proliferation contributes to autoimmune diseases such as lupus, rheumatoid arthritis and Sjogren syndrome.
• CRISPR knockout, knock-in and overexpression models enable causal testing of candidate regulators of mononuclear cell proliferation.
• The term is experimentally assayed by flow cytometry, CFSE dilution, thymidine incorporation and scRNA-seq.
Description
GO:0032946, positive regulation of mononuclear cell proliferation, is a Gene Ontology biological process term that captures any molecular event that activates or increases the frequency, rate or extent of proliferation of mononuclear cells. Mononuclear cells are a morphologically defined group of leukocytes with a single round nucleus, encompassing lymphocytes (T cells, B cells, NK cells) and monocytes. Their ability to clonally expand upon antigen encounter or cytokine stimulation is a cornerstone of adaptive immunity and inflammatory responses. Because excessive or misdirected mononuclear cell proliferation underlies multiple human diseases, understanding its positive regulation is of broad biomedical importance. At the molecular level, positive regulation of mononuclear cell proliferation is driven by cytokine-receptor signaling, costimulation, and intracellular metabolic and epigenetic reprogramming that together license cell-cycle entry. For example, engagement of the T-cell receptor together with CD28 costimulation and IL-2 receptor signaling activates STAT5 and NF-kB, which induce proliferation-associated genes. In disease settings such as systemic lupus erythematosus, homeostatic proliferation of T cells promotes a redox state that drives metabolic and epigenetic upregulation of inflammatory pathways, illustrating how positive regulation can become pathogenic. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to define GO:0032946, outline its mechanisms, highlight key genes, and describe experimental models including CRISPR-based knockout, point mutation, knock-in and overexpression systems for functional dissection.
positive regulation of mononuclear cell proliferation At A Glance
| GO ID | GO:0032946 |
|---|---|
| GO term | positive regulation of mononuclear cell proliferation |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation. |
| Synonyms | activation of mononuclear cell proliferation; positive regulation of PBMC proliferation; positive regulation of peripheral blood mononuclear cell proliferation; stimulation of mononuclear cell proliferation; up regulation of mononuclear cell proliferation; up-regulation of mononuclear cell proliferation; upregulation of mononuclear cell proliferation |
| Major function | Drives expansion of lymphocytes and monocytes during immune activation, inflammation and host defense. |
| Related cell types | T cells, B cells, NK cells, monocytes, peripheral blood mononuclear cells (PBMCs). |
| Disease relevance | Autoimmunity (lupus, rheumatoid arthritis, Sjogren syndrome), cancer, chronic inflammation. |
| Experimental readouts | Flow cytometry, CFSE dilution, thymidine incorporation, scRNA-seq. |
What Is GO:0032946?
According to the Gene Ontology, GO:0032946 (positive regulation of mononuclear cell proliferation) is defined as any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation. In other words, it is the set of signaling, transcriptional and metabolic events that push mononuclear cells such as T cells, B cells, NK cells and monocytes to enter and progress through the cell cycle more often or more rapidly than baseline.
Why Is positive regulation of mononuclear cell proliferation Important in Cell Biology?
Positive regulation of mononuclear cell proliferation is essential for mounting effective immune responses against pathogens and tumors, yet its dysregulation drives autoimmune pathology and chronic inflammation. Understanding the molecular switches that promote mononuclear cell expansion therefore informs vaccine design, cancer immunotherapy and the treatment of autoimmune diseases.
• Required for clonal expansion of T and B cells during adaptive immune responses.
• Drives monocyte and macrophage accumulation in inflammatory lesions.
• Dysregulated in systemic lupus erythematosus, where homeostatic proliferation promotes inflammatory reprogramming.
• Contributes to rheumatoid arthritis pathogenesis via T-cell activation.
• Linked to Sjogren syndrome-like symptoms in humanized mouse models.
• Central to CAR-T cell expansion and persistence in cancer immunotherapy.
• Modulated by microRNAs that fine-tune T-cell activation.
• Target of immunoregulatory neurohormonal signals.
• Relevant to breast cancer bone metastasis microenvironment.
• Provides a mechanistic readout for drug candidates targeting immune activation.
What Happens During positive regulation of mononuclear cell proliferation?
Antigen recognition and costimulation
In simple terms: A mononuclear cell first needs to recognize a specific signal and receive a second 'go' signal before it starts dividing.
Positive regulation of mononuclear cell proliferation is initiated when antigen-presenting cells engage the T-cell receptor or B-cell receptor, delivering signal one. Costimulatory interactions, such as CD28 binding to CD80/CD86, provide signal two and lower the threshold for activation. Without costimulation, cells may become anergic rather than proliferate, underscoring that positive regulation requires integration of multiple inputs.
Cytokine-driven signaling
In simple terms: Cytokines act like fuel pedals that push the cell to divide faster.
Cytokines such as IL-2 and IL-15 bind to their receptors and activate JAK-STAT pathways, particularly STAT5, which induces genes that promote cell-cycle entry. In lupus, homeostatic proliferation driven by cytokine signals promotes a redox state that metabolically and epigenetically upregulates inflammatory pathways. This illustrates how cytokine signaling can convert a normal proliferative response into a pathogenic one.
Transcriptional reprogramming
In simple terms: The cell switches on a set of genes that tell it to grow and divide.
Downstream of receptor signaling, transcription factors such as NF-kB, NFAT and STAT5 drive expression of proliferation-associated genes including cyclins and MYC. MicroRNAs also modulate this transcriptional program; for example, upregulation of T-cell activation microRNAs has been observed in drug-specific CD4+ T cells from hypersensitive patients. This layer of regulation ensures that proliferation is tightly coupled to the strength and duration of stimulation.
Metabolic and epigenetic remodeling
In simple terms: Dividing cells need extra energy and must unlock their DNA for growth genes.
Proliferating mononuclear cells undergo metabolic shifts toward glycolysis and glutaminolysis to support biomass production. In lupus T cells, homeostatic proliferation promotes a redox state that drives metabolic and epigenetic upregulation of inflammatory pathways, linking proliferation to lasting epigenetic changes. These changes can perpetuate inflammation even after the initial stimulus wanes.
Cell-cycle entry and division
In simple terms: Finally, the cell commits to dividing and produces daughter cells.
The integrated signals converge on the cell-cycle machinery, activating cyclin-dependent kinases and driving progression through G1/S and G2/M checkpoints. In CAR-T cells, persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice, demonstrating that sustained proliferative capacity is linked to therapeutic efficacy. Conversely, CAR-negative T cells can influence the efficacy and safety of CAR-T therapies, highlighting the importance of controlling which mononuclear cells proliferate.
Key Genes Involved in GO:0032946 positive regulation of mononuclear cell proliferation
The following genes and proteins are central to the positive regulation of mononuclear cell proliferation, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL2 | Cytokine that promotes T-cell proliferation via IL-2 receptor signaling | Target for enhancing CAR-T expansion |
| IL2RA | High-affinity IL-2 receptor alpha chain; mediates IL-2-driven proliferation | Marker of activated T cells; KO reduces proliferation |
| STAT5A | Transcription factor downstream of cytokine receptors; induces proliferation genes | Knockout impairs T-cell expansion |
| STAT5B | Paralog of STAT5A; contributes to cytokine-driven proliferation | Point mutations linked to immune dysregulation |
| NFKB1 | Transcription factor driving survival and proliferation genes | Knockout reduces mononuclear cell expansion |
| CD28 | Costimulatory receptor providing signal two for T-cell activation | Knockout causes anergy; target for CAR design |
| MYC | Oncogene and transcription factor promoting cell-cycle entry | Overexpression enhances proliferation |
| CCND1 | Cyclin D1; drives G1/S transition | Knockout blocks cell-cycle progression |
| GPC3 | Glypican 3; target antigen in CAR-T for hepatocellular carcinoma | Knock-in models for CAR-T testing |
| MIR24-2 | MicroRNA host gene; miR-24-2-5p has protective effects in breast cancer bone metastasis | Overexpression reduces metastatic niche proliferation |
| MIR21 | MicroRNA upregulated in activated T cells; modulates proliferation | Knockout alters T-cell activation |
| PTPRC | CD45; regulates T-cell receptor signaling threshold | Knockout affects proliferation capacity |
| FOXP3 | Regulatory T-cell transcription factor; suppresses proliferation | Knockout causes autoimmune proliferation |
| IL15 | Cytokine promoting NK and T-cell proliferation | Overexpression enhances NK expansion |
| TNF | Proinflammatory cytokine that can promote mononuclear cell proliferation | Knockout reduces arthritis severity |
| IL6 | Cytokine driving STAT3-dependent proliferation | Knockout attenuates rheumatoid arthritis models |
| CD4 | Coreceptor defining helper T cells | Depletion models study Tph/Tfh proliferation |
| CD8A | Coreceptor defining cytotoxic T cells | Depletion promotes Tph/Tfh proliferation in humanized mice |
How Is positive regulation of mononuclear cell proliferation Regulated?
Positive regulation of mononuclear cell proliferation is controlled by a multilayered network. Cytokine-receptor signaling through JAK-STAT pathways, especially STAT5, provides a major positive input. Costimulatory signals via CD28 amplify T-cell receptor signaling, while coinhibitory receptors such as CTLA-4 and PD-1 restrain it. Neurohormonal immunoregulation also modulates these processes, as reviewed by Istvan. MicroRNAs fine-tune the intensity of activation; for example, upregulation of T-cell activation microRNAs occurs in drug-specific CD4+ T cells from hypersensitive patients. Metabolic and epigenetic remodeling further shapes proliferative capacity, as seen in lupus T cells where homeostatic proliferation drives inflammatory reprogramming. Finally, the balance between effector and regulatory T cells, influenced by FOXP3, determines net proliferation.
positive regulation of mononuclear cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT5A | Lupus; cytokine-driven T-cell proliferation | Knockout mice; Jurkat T cells |
| CD28 | Rheumatoid arthritis; costimulation | Knockout mice; human PBMC assays |
| GPC3 | Hepatocellular carcinoma; CAR-T target | Knock-in mice; orthotopic tumor models |
| MIR24-2 | Breast cancer bone metastasis | Overexpression in breast cancer cell lines |
| CD8A | Sjogren syndrome; Tph/Tfh proliferation | Humanized mice; PBMC engraftment |
Autoimmune diseases
Dysregulated positive regulation of mononuclear cell proliferation is a hallmark of autoimmunity. In systemic lupus erythematosus, T-cell homeostatic proliferation promotes a redox state that drives metabolic and epigenetic upregulation of inflammatory pathways, perpetuating disease. In rheumatoid arthritis, T-cell activities are regulated by fusion proteins such as IgD-Fc-Ig, which can modulate proliferation. In Sjogren syndrome, CD8+ T-cell depletion promotes human Tph/Tfh cell proliferation and Sjogren syndrome-like symptoms in PBMC-based humanized mice, directly linking mononuclear cell proliferation to disease pathogenesis.
Cancer and immunotherapy
In cancer, the goal of adoptive cell therapy is to harness positive regulation of mononuclear cell proliferation for therapeutic benefit. Persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice, demonstrating that sustained proliferation and effector function are critical for efficacy. However, CAR-negative T cells can influence the efficacy and safety of CAR-T therapies, highlighting the need to understand which mononuclear cells expand. In breast cancer bone metastasis, miR-24-2-5p has protective effects in early stages, suggesting that microRNA-mediated regulation of proliferation in the metastatic niche can be therapeutically exploited.
Hypersensitivity and immune regulation
Drug hypersensitivity reactions involve upregulation of T-cell activation microRNAs in drug-specific CD4+ T cells, indicating that positive regulation of mononuclear cell proliferation contributes to adverse drug reactions. Neurohormonal immunoregulation provides another layer of control, with hormones and neurotransmitters capable of modulating mononuclear cell proliferation. These examples illustrate that both excessive and insufficient positive regulation can have clinical consequences.
From positive regulation of mononuclear cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote T-cell proliferation? | CRISPR knockout in primary human T cells followed by CFSE dilution |
| Does a point mutation in STAT5B alter proliferation? | Point-mutation knock-in in Jurkat cells |
| Can overexpression of MYC enhance mononuclear cell expansion? | Lentiviral overexpression in PBMCs |
| Does a tagged knock-in of IL2RA affect receptor trafficking? | CRISPR knock-in of fluorescent tag |
| Which genes regulate CAR-T persistence? | CRISPR library screening in CAR-T cells |
| Does CD8+ T-cell depletion alter Tph/Tfh proliferation? | Humanized mouse model with PBMC engraftment |
How to Study the positive regulation of mononuclear cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CFSE dilution flow cytometry | Number of cell divisions | T-cell proliferation assays |
| BrdU/thymidine incorporation | DNA synthesis rate | PBMC stimulation assays |
| scRNA-seq | Transcriptional states of proliferating cells | Discovery of novel regulators |
| CRISPR knockout screen | Genes required for proliferation | Functional genomics |
| CRISPR activation screen | Genes sufficient to enhance proliferation | Pathway discovery |
| Western blot | Protein expression of cyclins and STATs | Validation of signaling changes |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Metabolic reprogramming studies |
| ELISA | Cytokine production (IL-2, IFN-gamma) | Functional readout of activation |
Flow cytometry and CFSE dilution
Flow cytometry with CFSE or CellTrace Violet dilution is the gold-standard method to measure mononuclear cell proliferation, as each cell division halves the dye intensity. This approach allows simultaneous staining of surface markers to identify T-cell, B-cell, NK-cell and monocyte subsets.
Thymidine incorporation and metabolic assays
Tritiated thymidine or BrdU incorporation measures DNA synthesis and thus proliferation rate. Metabolic assays such as Seahorse extracellular flux analysis can reveal the bioenergetic changes that accompany proliferation, as seen in lupus T cells.
Transcriptomics and single-cell RNA-seq
Bulk RNA-seq and single-cell RNA-seq can identify transcriptional programs associated with positive regulation of mononuclear cell proliferation. These methods are particularly useful for discovering novel regulators and for validating CRISPR screens.
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens enable unbiased discovery of genes that positively regulate mononuclear cell proliferation. Hits can be validated individually using flow cytometry-based proliferation assays.
How CRISPR Can Be Used to Study GO:0032946 positive regulation of mononuclear cell proliferation
Knockout
CRISPR knockout of candidate genes such as STAT5A, CD28 or MYC in primary human T cells or Jurkat cells can causally test their requirement for positive regulation of mononuclear cell proliferation. Knockout cells are then stimulated and assessed by CFSE dilution or thymidine incorporation.
Point Mutation
Point mutations can model human variants that alter proliferative capacity. For example, knock-in of a STAT5B point mutation can reveal gain-of-function or loss-of-function effects on cytokine-driven proliferation. This approach is valuable for precision immunology.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci such as IL2RA or GPC3 allows tracking of receptor dynamics and CAR-T target expression. Knock-in models also enable physiological expression levels, avoiding artifacts of overexpression.
Overexpression
Overexpression of positive regulators like MYC or IL2 can enhance mononuclear cell proliferation and is useful for generating expanded cell products for immunotherapy. Overexpression of miR-24-2-5p has been used to study protective effects in breast cancer bone metastasis.
How EDITGENE Supports positive regulation of mononuclear cell proliferation Research
Researchers studying positive regulation of mononuclear cell proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or restraining cell expansion. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mononuclear cell proliferation research.
Frequently Asked Questions About positive regulation of mononuclear cell proliferation
What is GO:0032946?
GO:0032946 is the Gene Ontology term for positive regulation of mononuclear cell proliferation, defined as any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation.
What genes are involved in positive regulation of mononuclear cell proliferation?
Key genes include IL2, IL2RA, STAT5A, STAT5B, NFKB1, CD28, MYC, CCND1, GPC3, MIR24-2, MIR21, PTPRC, FOXP3, IL15, TNF, IL6, CD4 and CD8A.
How is mononuclear cell proliferation measured?
Common methods include CFSE dilution flow cytometry, BrdU or thymidine incorporation, and scRNA-seq.
What diseases involve dysregulated mononuclear cell proliferation?
Autoimmune diseases such as lupus, rheumatoid arthritis and Sjogren syndrome, as well as cancer and drug hypersensitivity.
What is the role of STAT5 in mononuclear cell proliferation?
STAT5A and STAT5B are transcription factors downstream of cytokine receptors that induce proliferation-associated genes.
How do CRISPR knockouts help study GO:0032946?
CRISPR knockout of candidate genes in primary T cells or cell lines allows causal testing of their requirement for proliferation.
What is the difference between positive and negative regulation of mononuclear cell proliferation?
Positive regulation increases proliferation frequency or rate, while negative regulation decreases it; both are essential for immune homeostasis.
Which cytokines promote mononuclear cell proliferation?
IL-2, IL-15 and IL-6 are well-known promoters of mononuclear cell proliferation.
Can microRNAs regulate mononuclear cell proliferation?
Yes, microRNAs such as miR-24-2-5p and T-cell activation microRNAs modulate proliferation.
What models are used to study positive regulation of mononuclear cell proliferation?
Models include primary human T cells, Jurkat cells, humanized mice and CAR-T cells.
Conclusion
GO:0032946, positive regulation of mononuclear cell proliferation, is a fundamental biological process that governs the expansion of lymphocytes and monocytes during immune responses. Its dysregulation contributes to autoimmunity, cancer and hypersensitivity, making it a critical area of research. By leveraging CRISPR knockout, point mutation, knock-in and overexpression models, researchers can causally dissect the molecular players involved and identify new therapeutic targets.
References
- 1. Li D et al.. 2020. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.. Gastroenterology 158(8):2250-2265.e20 PMID: 32060001
- 2. Sierro-Martínez B et al.. 2025. Unveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapies.. J Transl Med 23(1):942 PMID: 40830482
- 3. Istvan B. 1990. Neurohormonal immunoregulation.. Endocr Pathol 1(4):197-219 PMID: 32357612
- 4. Puppo M et al.. 2024. Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.. Breast Cancer Res 26(1):186 PMID: 39696397
- 5. Monroy-Arreola A et al.. 2018. Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4(+) T-Cells from Hypersensitive Patients.. Chem Res Toxicol 31(6):454-461 PMID: 29644860
- 6. Budd RC et al.. 2022. T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus.. Antioxid Redox Signal 36(7-9):410-422 PMID: 34328790
- 7. Piruzyan M et al.. 2025. CD8+ T cell depletion promotes human Tph/Tfh cell proliferation and Sjögren syndrome-like symptoms in PBMC-based humanized mice.. JCI Insight 10(22) PMID: 41277554
- 8. Zhang J et al.. 2020. Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig.. Front Immunol 11:755 PMID: 32499775
